27 Sep ARU collaborates on new childhood cancer project
Anglia Ruskin University (ARU) is collaborating with Scottish biopharmaceutical company Medannex on a £313,000 project to develop a new treatment for a childhood bone cancer. Thanks to funding from Innovate UK’s Cancer Therapeutics programme, Medannex will work with senior scientists at ARU’s School of Life...